Evaluation of a Best-Practice Model for Multiprofessional Medication Management in Cancer Patients

Evaluation of a Best-Practice Model for Multiprofessional Medication Management in Cancer Patients - MuMM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010128

Enrollment

Registered

2016-03-07

Start date

2012-11-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Patient care based on the developed multiprofessional medication managenemt provided by physician, pharmacist and nurse for a maximum of six treatment cycles Group 2: Standard patient care pr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of a solid tumor; outpatient tumor treatment in the Oncological Outpatient Department of Internal Oncology of the Johanniter Hospital in Bonn; written consent of the patient; ability to speak and understand German

Exclusion criteria

Exclusion criteria: Diseases where the patient is unable to understand the type and content of the study and it can be excluded that the patient correctly understands the questionnaire or is able to fill it out on his own (e.g. Alzheimer's disease); intention to change the location of treatment in the near future

Design outcomes

Primary

Measure	Time frame
Percentage of patients with at least one toxicity score 3-4 according to PRO-CTCAE referring to the symptoms nausea and vomiting, mucositis, fatigue, pain, diarrhea, constipation, dry mouth, dysphagia, loss of appetite, sleep disorders (at the beginning of every treatment cycle retrospectively assessed over the past seven days for a maximum of six treatment cycles)	—

Secondary

Measure	Time frame
Percentage of patients with toxicity, i.e. with score >0 according to PRO-CTCAE (at the beginning of every treatment cycle); quality of life for the patients using EORTC QLQ-C30 questionnaire and EQ-5D-3L questionnaire (at the beginning of every treatment cycle); patient satisfaction with the information on cancer treatment according to PS-CaTE (at the beginning of the first and last treatment cycle); frequency of occurrence of malnutrition (SGA category C) (at the beginning of every treatment cycle); percentage of patients with current, written medication plan (at the beginning of every treatment cycle)	—

Measure

Time frame

Percentage of patients with toxicity, i.e. with score >0 according to PRO-CTCAE (at the beginning of every treatment cycle); quality of life for the patients using EORTC QLQ-C30 questionnaire and EQ-5D-3L questionnaire (at the beginning of every treatment cycle); patient satisfaction with the information on cancer treatment according to PS-CaTE (at the beginning of the first and last treatment cycle); frequency of occurrence of malnutrition (SGA category C) (at the beginning of every treatment cycle); percentage of patients with current, written medication plan (at the beginning of every treatment cycle)

—

Countries

Germany

Contacts

Public ContactUlrich Jaehde

Klinische Pharmazie

u.jaehde@uni-bonn.de0228-735252

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026